DE-URSIL RR caps 450 mg 20 pce

7680446190065 CH-44619 A05AA02 04.99.0.

Reimbursement limitations:

DEURSIL

Pour les calculs de Cholésterol et la cirrhose biliaire primitive (CBP).

DE-URSIL RR caps 450 mg 20 pce
DE-URSIL RR caps 450 mg 20 pce
DE-URSIL RR caps 450 mg 20 pce
1 / 3
google

Details

Product number
4461901
CPT
-
Packaging group
20
Unit
Kapsel(n)
Composition
acidum ursodeoxycholicum 450 mg, talcum, cellulosum microcristallinum, carmellosum natricum conexum, carmellosum natricum, E 218 0.18 mg, gelatina, sorbitolum 2.82 mg, povidonum K 90, magnesii stearas, Überzug: acidi methacrylici et methylis methacrylatis polymerisatum 1:1, tributylis citras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, macrogolum 6000, E 171, E 172 (rubrum), talcum, Kapselhülle: gelatina, pro capsula corresp. natrium 0.66 mg.

Articles (1)

De-ursil RR 450 mg, Hartkapseln, retardiert
Kapseln
20
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
450.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.18 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
2.82 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.66 MG Substance HBESI

Reimbursement information

Public price
CHF 45.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1984

Authorization holder

Cheplapharm Schweiz GmbH

4102 Binningen

Authorization information

Swissmedic authorization number
44619
Drug name
De-ursil RR, Hartkapseln, retardiert
Galenic form
RETH
ATC Code
A05AA02
Authorization status
Z
Dispensation category
B
First authorization
28/06/1983
Authorization expiration date
31/12/9999
IT number
04.99.0.
Domain
Human medicine
Field of application
Behandlung von Gallensteinen, Cholangitis

Packaging details

Description (FR)
DE-URSIL RR caps 450 mg 20 pce
Description (DE)
DE-URSIL RR Kaps 450 mg 20 Stk
Market launch
28/06/1983
Narcotic (BTM)
No

Other packaging sizes

DE-URSIL RR caps 450 mg 10 pce
10 KAP
View
DE-URSIL RR caps 450 mg 60 pce
60 KAP
View
DE-URSIL RR Mite caps 225 mg 20 pce
20 KAP
View